Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.

PLoS One · 2013 · PMC3749194 · PMID 23990986

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

showed a trendp = 0.068so close (0.05 < p ≤ 0.1)

PDGFRA positive glioblastoma cases showed a trend towards IDH1 mutation (7/8, 87.5% IDH1 mutant tumours positive for PDGFRA vs 135/263, 51.3% IDH1 wild-type, p = 0.068, Fishers exact test), and exhibited a similar distribution of predominant glioblastoma morphologies as for PDGFRA gene amplification ( Figure 4B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.